% | $
Quotes you view appear here for quick access.

StarTek, Inc. Message Board

  • lloyd_barclay lloyd_barclay Mar 11, 2008 8:36 PM Flag

    Good Value

    Despite the loss of the dividend, Startek (SRT) is still a good investment.

    At $8.30, it is trading at less than half of fair value in relation to sales, book value and its own trading history.

    In relation to other companies in the Business Services Industry, the price/sales ratio is about 0.48, compared to the average of 2.73. Sales/share is $16.19. If we multiply its sales/share by the industry average, we get:
    $16.69 X 2.39 = $45.56

    The forward price/earnings ratio is not exactly cheap at 18.4, but the low psr gives substantial potential to increase profits with higher margins. Higher profits will, in turn, lower the price/earnings ratio.

    The average price/sales ratio in the industry, however, may be unrealistic for Startek. To allow for a margin of safety, we can use a more conservative psr of 1.5.
    $16.69/share X 1.5 = $25

    SRT is also cheap in relation to book value. The price/book ratio is 1.0 , while the industry average is 3.74. SRT has a book value of about $8/share. If we multiply the book value by the industry average, we get:
    $8/share X 3.74 = $29.92

    Contrarian Calculation
    SRT is also good value in relation to its own trading history. Over the last 10 years, it's been as high as $62 and as low as about $9. Averaging these 2 extremes, we get:
    ($62 + $9)/2 = $35.50

    This means that, at $8.30, SRT is trading at less than one quarter of its "average" price of the last 10 years.

    Futhermore, the low debt/equity ratio of 0.1 shows that the company is financially stable and well-managed.

    The Insider Story
    A high-ranking insider purchased 10,000 shares at a price of $8.95/share, in December of 2007.
    The most conservative estimate of StarTek's fair value is about $24. At anything under $12, the stock therefore has good potential to double. It may take 3 to 5 years to double, but that provides a good rate of return for patient investors.

    To view a portfolio of thoroughly-researched value-contrarian stocks, please visit my investment website at:

    Best regards,

    Lloyd Barclay

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Congratulations on winning the idiot post this quarter Lloyd Barclay. Maybe in the future you should actually do some research on the company before offering this "expert" analysis.

      I would point out the fact in answer to all your points but frankly I don't have the time or patience to educate you about this company.

4.50-0.12(-2.60%)Jun 27 4:02 PMEDT